United Kingdom · 
Who invested in Laverock Therapeutics?
Laverock Therapeutics's investors include Eli Lilly, Maven Capital Partners, Future Planet Capital and Mercia Asset Management.
2026
?Venture$3.0MGrant
United Kingdom · Funded startup
Who invested in Laverock Therapeutics
Funding summaryUpdated 26 Oct 2026
$3.0Mraised across 2 rounds since 2025, from 2 sources
- Latest round
- Grant, $3.0MJun 2026
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture Jun 2025
- Biggest round
- $3.0M Grant · Jun 2026
- Between rounds
- 12 months from the last two
The rounds
- Jun 2026Grant$3.0M4 returning
Source recorded
- Jun 2025VentureAmount undisclosed4 new
Source recorded
Founders and team
From Laverock Therapeutics's own website: 3 on the team.
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Laverock Therapeutics
How much has Laverock Therapeutics raised?
Laverock Therapeutics has raised $3.0M across 2 rounds since 2025. One round did not disclose an amount, so the total is a floor.
When did Laverock Therapeutics last raise?
Laverock Therapeutics's most recent round was a Grant of $3.0M in Jun 2026.
What was Laverock Therapeutics's biggest round?
Its most recent round, $3.0M in Jun 2026, is also its largest on record.
Who backed Laverock Therapeutics first?
Laverock Therapeutics's first round on record, in Jun 2025, was backed by Eli Lilly, Maven Capital Partners and Future Planet Capital and 1 others.
What stage is Laverock Therapeutics at?
Laverock Therapeutics's latest named round is a Grant, in Jun 2026.
Where is Laverock Therapeutics based?
Laverock Therapeutics is based in the United Kingdom.
Companies like Laverock Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.